Home/Smart Money/MONTANOVA CAPITAL, LLC
§ 13F · FUND PROFILE

MONTANOVA CAPITAL, LLC.

AUM · $5.5B (13F)Positions · 96Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
No new positions
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS

The book · Q2 2026

FILED AUG 14, 2026
#TickerNameShares$ value% portΔ Q2
1SPYSTATE STR SPDR S&P 500 ETF T950K$709M
2MANEVERADERMICS INC4.17M$513M
3ARQTARCUTIS BIOTHERAPEUTICS INC12.44M$326M
4LEGNLEGEND BIOTECH CORP7.07M$204M
5PVLAPALVELLA THERAPEUTICS INC NE1.14M$174M
6AVBPARRIVENT BIOPHARMA INC4.52M$157M
7BNTCBENITEC BIOPHARMA INC11.55M$155M
8BHVNBIOHAVEN LTD10.29M$153M
9AMDADVANCED MICRO DEVICES INC257K$149M
10RCUSARCUS BIOSCIENCES INC4.78M$147M
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE MONTANOVA SIGNAL

AC read

MONTANOVA CAPITAL, LLC is a Other fund managing $5.5 billion in assets. The fund runs a portfolio of 96 positions.

Read the full dossier →